Nordic Infucare was founded in 2004 and the hard work of its 50 employees makes it today one of the fastest companies in its industry.
2004: Nordic Infucare is founded by Mats Bergryd. The company sells infusion devices for Immunodefficiency, PAH, and Parkinson disease to hospitals and clinics. It starts in Sweden, but quickly opens an activity in Norway.
2005: Nordic Infucare starts operating in Denmark
- 2013: Nordic Infucare establishes its own activity in Finland and therefore becomes a Nordic organisation. The company is leader in PAH and Parkinson late stage treatments. The same year, Nordic Infucare is acquired by Air Liquide Healthcare
2014: Nordic Infucare accelerate its expansion in Diabetes with the launch of Dexcom G4®, a state-of-the-art Continuous Glucose Monitoring system
2015: Launch of Dexcom G5®, the first completely mobile continuous glucose monitoring system sending glucose readings to a compatible smart device
2016: Launch of D-mine Pen®, innovative late stage Parkinson disease infusion pen
- 2017: Nordic Infucare reaches 50 employees and serves more than 6,000 patients in the Nordics